Accepted for Publication: August 25, 2022.
Published: October 12, 2022. doi:10.1001/jamanetworkopen.2022.36057
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Durstenfeld MS et al. JAMA Network Open.
Corresponding Author: Matthew S. Durstenfeld, MD, MAS, Division of Cardiology, University of California, San Francisco at Zuckerberg San Francisco General Hospital, 1001 Potrero Ave, Room 5G8, San Francisco, CA 94110 (matthew.durstenfeld@ucsf.edu).
Author Contributions: Dr Durstenfeld had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Durstenfeld, Sun, Peluso, Long, Hsue.
Acquisition, analysis, or interpretation of data: Durstenfeld, Tahir, Peluso, Deeks, Aras, Grandis, Beatty, Hsue.
Drafting of the manuscript: Durstenfeld, Sun, Tahir.
Critical revision of the manuscript for important intellectual content: Tahir, Peluso, Deeks, Aras, Grandis, Long, Beatty, Hsue.
Statistical analysis: Durstenfeld, Sun, Peluso.
Obtained funding: Durstenfeld, Peluso, Grandis, Long.
Administrative, technical, or material support: Durstenfeld, Tahir, Peluso, Deeks.
Supervision: Peluso, Aras, Grandis, Beatty, Hsue.
Conflict of Interest Disclosures: Dr Beatty reported receiving a salary in 2018 and 2019 and stock from 2019 to 2021 from Apple Inc and receiving grants from the National Heart, Lung, and Blood Institute (NHLBI) outside the submitted work. Dr Hsue reported receiving honoraria from Gilead Sciences Inc and Merck & Co Inc and receiving grants from Novartis AG outside the submitted work. No other disclosures were reported.
Funding/Support: This study was funded by grant K12 HL143961 from the NHLBI.
Role of the Funder/Sponsor: The sponsor had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.